✦ LIBER ✦

Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon

✍ Scribed by Toshinori Kodama; Shigeo Katabami; Keiichi Kamijo; Akio Katanuma; Kentaro Yamashita; Naoki Azuma; Tomohiro Tamaki; Akira Yachi

Publisher: Springer Japan
Year: 1994
Tongue: English
Weight: 364 KB
Volume: 29
Category: Article
ISSN: 0944-1174
DOI: 10.1007/bf02358367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thyroid autoantibodies and thyroid dysfu

Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-α for chronic hepatitis C

✍ Karlheinz Kiehne; Sievert Kloehn; Holger Hinrichsen; Baptist Gallwitz; Heiner Mö 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 445 KB

Development of myasthenia gravis during

Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin

✍ Christine J. Weegink; Robert A. F. M. Chamuleau; Henk W. Reesink; Delmar S. M. M 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 35 KB

Re-treatment of chronic hepatitis C with

Re-treatment of chronic hepatitis C with consensus interferon

✍ E. Jenny Heathcote; Emmet B. Keeffe; Samuel S. Lee; Saya V. Feinman; Myron J. To 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Peripheral insulin resistance during tre

Peripheral insulin resistance during treatment of chronic hepatitis C with peguilated interferon plus ribavirin

✍ Vivianne Mello; Thomaz Cruz; Geila Nuñez; Maria Tereza Simões; Fabrizio Ney-Oliv 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Patients with hepatitis C virus (HCV) infection present higher risk of developing type-2 diabetes mellitus (DM). However, the mechanism of this association and the role of antiviral treatment are still unclear. The objective of this study was to investigate the relationship between the use of peguil

Re-treatment with interferon alfa of pat

Re-treatment with interferon alfa of patients with chronic hepatitis C

✍ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res

Relationship between biochemical, virolo

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C

✍ M L Shiffman; C M Hofmann; E B Thompson; A Ferreira-Gonzalez; M J Contos; A Kosh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB 👁 1 views

The response to interferon treatment for patients with The present study was conducted to evaluate the relationship between biochemical, virological, and histological re-chronic hepatitis C was originally defined biochemically as a decline in the value of an elevated serum alanine amino-sponse durin